pLKO5.U6.DR130(CasRX)_Empty.EFS.tRFP657 Citations (2)

Originally described in: Genome-scale pan-cancer interrogation of lncRNA dependencies using CasRx.
Montero JJ, Trozzo R, Sugden M, Ollinger R, Belka A, Zhigalova E, Waetzig P, Engleitner T, Schmidt-Supprian M, Saur D, Rad R Nat Methods. 2024 Feb 26. doi: 10.1038/s41592-024-02190-0. PubMed Journal

Articles Citing pLKO5.U6.DR130(CasRX)_Empty.EFS.tRFP657

Articles
Genome-scale pan-cancer interrogation of lncRNA dependencies using CasRx. Montero JJ, Trozzo R, Sugden M, Ollinger R, Belka A, Zhigalova E, Waetzig P, Engleitner T, Schmidt-Supprian M, Saur D, Rad R. Nat Methods. 2024 Feb 26. doi: 10.1038/s41592-024-02190-0. PubMed Associated Plasmids pLKO5.U6.DR130(CasRX)_Empty.EFS.tRFP657 pLKO5.U6.DR130(CasRX)_Non-targeting sgRNA.EFS.tRFP657 pLKO5.U6.DR130(CasRX)_GFP-targeting sgRNA.EFS.tRFP657 pTransposon.CAG.CasRX-P2A-Blast Pan-cancer CasRx lncRNA Albarossa library
PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1. Zhu L, Qu Y, Yang J, Shao T, Kuang J, Liu C, Qi Y, Li M, Li Y, Zhang S, Wang J, Liu Y, Liu J, Hu Y, Zhu L, Hou T. Front Immunol. 2024 Dec 2;15:1486888. doi: 10.3389/fimmu.2024.1486888. eCollection 2024. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.